跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI
Approved
STANDARD
T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e048b2073adb62e9
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
e048b2073adb62e9
Product Name
T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI
Artg Id
410143
Artg Name
Cellular Therapies - T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI - Janssen-Cilag Pty Ltd - Injection, intravenous infusion - Bag
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2023-06-06
Registration Type
Biological
Therapeutic Good Type
Biological
Licence Status
A
Licence Category
INC
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01765-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01764-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e048b2073adb62e9
Type
Standard
Back to TGA Approvals
T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI - TGA Drug Approval Details